Literature DB >> 2823318

Nomenclature of lipoxins and related compounds derived from arachidonic acid and eicosapentaenoic acid.

C N Serhan1, P Y Wong, B Samuelsson.   

Abstract

Oxygenated derivates of arachidonic acid and eicosapentaenoic acid which contain conjugated tetraene structures and are non-cyclized C20 carboxylic acids were first isolated and characterized from human and porcine leukocytes (Serhan, C.N. et al, 1984, Biochem. Biophys. Res. Commun. 118, 943-949; Wong, P.Y.-K., et al, 1985, Biochem. Biophys. Res. Commun. 126, 765-775). The trivial names lipoxins and lipoxenes have been introduced for compounds belonging to each of these series. Here, we propose that tetraene-containing compounds derived from arachidonic acid be denoted as lipoxins (LX) of the four series (i.e. lipoxin A4 or LXA4 and lipoxin B4 or LXB4) and those derived from eicosapentaenoic be termed lipoxins of the five series (i.e. lipoxin A5 or LXA5 and lipoxin B5 or LXB5).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823318     DOI: 10.1016/0090-6980(87)90243-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  6 in total

1.  A suggested shorthand nomenclature for the eicosanoids.

Authors:  D L Smith; A L Willis
Journal:  Lipids       Date:  1987-12       Impact factor: 1.880

2.  Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.

Authors:  Kaustubh Parashar; Fabian Schulte; Markus Hardt; Olga J Baker
Journal:  FASEB J       Date:  2020-04-11       Impact factor: 5.191

Review 3.  Lipoxins: eicosanoids carrying intra- and intercellular messages.

Authors:  C N Serhan
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

4.  5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors.

Authors:  C Chavis; I Vachier; P Chanez; J Bousquet; P Godard
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

5.  Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.

Authors:  C N Serhan; C B Clish; J Brannon; S P Colgan; N Chiang; K Gronert
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

6.  AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.

Authors:  Justin T Easley; Christina L M Maruyama; Ching-Shuen Wang; Olga J Baker
Journal:  Physiol Rep       Date:  2016-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.